- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-MMP7/ MMP-7/ MPSL1 functional antibody
Anti-MMP7/ MMP-7/ MPSL1 functional antibody for cell culture, ELISA & in-vivo assay
Go to MMP-7/MMP7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T73475-Ab-1/ GM-Tg-hg-T73475-Ab-2 | Anti-Human MMP-7/MMP7 monoclonal antibody | Human |
| GM-Tg-rg-T73475-Ab-1/ GM-Tg-rg-T73475-Ab-2 | Anti-Rat MMP-7/MMP7 monoclonal antibody | Rat |
| GM-Tg-mg-T73475-Ab-1/ GM-Tg-mg-T73475-Ab-2 | Anti-Mouse MMP-7/MMP7 monoclonal antibody | Mouse |
| GM-Tg-cynog-T73475-Ab-1/ GM-Tg-cynog-T73475-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MMP-7/MMP7 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T73475-Ab-1/ GM-Tg-felg-T73475-Ab-2 | Anti-Feline MMP-7/MMP7 monoclonal antibody | Feline |
| GM-Tg-cang-T73475-Ab-1/ GM-Tg-cang-T73475-Ab-2 | Anti-Canine MMP-7/MMP7 monoclonal antibody | Canine |
| GM-Tg-bovg-T73475-Ab-1/ GM-Tg-bovg-T73475-Ab-2 | Anti-Bovine MMP-7/MMP7 monoclonal antibody | Bovine |
| GM-Tg-equg-T73475-Ab-1/ GM-Tg-equg-T73475-Ab-2 | Anti-Equine MMP-7/MMP7 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-T73475-Ab-1/ GM-Tg-hg-T73475-Ab-2; GM-Tg-rg-T73475-Ab-1/ GM-Tg-rg-T73475-Ab-2; GM-Tg-mg-T73475-Ab-1/ GM-Tg-mg-T73475-Ab-2; GM-Tg-cynog-T73475-Ab-1/ GM-Tg-cynog-T73475-Ab-2; GM-Tg-felg-T73475-Ab-1/ GM-Tg-felg-T73475-Ab-2; GM-Tg-cang-T73475-Ab-1/ GM-Tg-cang-T73475-Ab-2; GM-Tg-bovg-T73475-Ab-1/ GM-Tg-bovg-T73475-Ab-2; GM-Tg-equg-T73475-Ab-1/ GM-Tg-equg-T73475-Ab-2 |
| Products Name | Anti-MMP-7/MMP7 monoclonal antibody |
| Format | mab |
| Target Name | MMP-7 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-MMP-7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-T73475-Ag-1 | Recombinant multi-species MMP7/ MMP-7/ MPSL1 protein |
| ORF Viral Vector | vGMLP003953 | human MMP7 Lentivirus particle |
| ORF Viral Vector | pGMLP003953 | human MMP7 Lentivirus plasmid |
| ORF Viral Vector | pGMLPm000654 | mouse Mmp7 Lentivirus plasmid |
| ORF Viral Vector | vGMLPm000654 | mouse Mmp7 Lentivirus particle |
Target information
| Target ID | GM-T73475 |
| Target Name | MMP-7 |
| Gene ID | 4316,17393,25335,703072,489432,727698,286794,100068985 |
| Gene Symbol and Synonyms | MAT,Matrilysin,MMP-7,MMP7,MPMM,MPSL1,PUMP-1 |
| Uniprot Accession | P09237,P50280,P55032 |
| Uniprot Entry Name | MMP7_HUMAN,MMP7_RAT,MMP7_FELCA |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target |
| Disease | Ovary Cancer, Chronic Kidney Disease |
| Gene Ensembl | ENSG00000137673 |
| Target Classification | N/A |
The target: MMP-7, gene name: MMP7, also named as MMP-7, MPSL1, PUMP-1. This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down proteoglycans, fibronectin, elastin and casein and differs from most MMP family members in that it lacks a conserved C-terminal hemopexin domain. The enzyme is involved in wound healing, and studies in mice suggest that it regulates the activity of defensins in intestinal mucosa. The gene is part of a cluster of MMP genes on chromosome 11. This gene exhibits elevated expression levels in multiple human cancers. [provided by RefSeq, Jan 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
